452 related articles for article (PubMed ID: 31801970)
1. Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.
Filippou PS; Karagiannis GS; Constantinidou A
Oncogene; 2020 Mar; 39(10):2040-2054. PubMed ID: 31801970
[TBL] [Abstract][Full Text] [Related]
2. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
[TBL] [Abstract][Full Text] [Related]
3. Midkine promotes breast cancer cell proliferation and migration by upregulating NR3C1 expression and activating the NF-κB pathway.
Zhang L; Song L; Xu Y; Xu Y; Zheng M; Zhang P; Wang Q
Mol Biol Rep; 2022 Apr; 49(4):2953-2961. PubMed ID: 35028860
[TBL] [Abstract][Full Text] [Related]
4. Expression of the heparin-binding growth factors Midkine and pleiotrophin during ocular development.
Cui R; Lwigale P
Gene Expr Patterns; 2019 Jun; 32():28-37. PubMed ID: 30825522
[TBL] [Abstract][Full Text] [Related]
5. Extracellular vesicles derived from pancreatic cancer cells are enriched in the growth factor Midkine.
Casari I; Emmanouilidi A; Domenichini A; Falasca M
Adv Biol Regul; 2022 Jan; 83():100857. PubMed ID: 34916167
[TBL] [Abstract][Full Text] [Related]
6. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases.
Jones DR
Br J Pharmacol; 2014 Jun; 171(12):2925-39. PubMed ID: 24460734
[TBL] [Abstract][Full Text] [Related]
7. The role of midkine in health and disease.
Neumaier EE; Rothhammer V; Linnerbauer M
Front Immunol; 2023; 14():1310094. PubMed ID: 38098484
[TBL] [Abstract][Full Text] [Related]
8. Proangiogenic factor midkine is increased in melanoma patients with sleep apnea and induces tumor cell proliferation.
Cubillos-Zapata C; Martínez-García MÁ; Díaz-García E; Toledano V; Campos-Rodríguez F; Sánchez-de-la-Torre M; Nagore E; Martorell-Calatayud A; Hernández Blasco L; Pastor E; Abad-Capa J; Montserrat JM; Cabriada-Nuño V; Cano-Pumarega I; Corral-Peñafiel J; Arias E; Mediano O; Somoza-González M; Dalmau-Arias J; Almendros I; Farré R; López-Collazo E; Gozal D; García-Río F;
FASEB J; 2020 Dec; 34(12):16179-16190. PubMed ID: 33058223
[TBL] [Abstract][Full Text] [Related]
9. The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment.
Bilir A; Aynacioglu AS; Tuna MY
Crit Rev Oncog; 2019; 24(1):35-45. PubMed ID: 31679218
[TBL] [Abstract][Full Text] [Related]
10. USP12 promotes breast cancer angiogenesis by maintaining midkine stability.
Sheng B; Wei Z; Wu X; Li Y; Liu Z
Cell Death Dis; 2021 Nov; 12(11):1074. PubMed ID: 34759262
[TBL] [Abstract][Full Text] [Related]
11. Midkine lacking its last 40 amino acids acts on endothelial and neuroblastoma tumor cells and inhibits tumor development.
Dianat N; Le Viet B; Gobbo E; Auger N; Bièche I; Bennaceur-Griscelli A; Griscelli F
Mol Cancer Ther; 2015 Jan; 14(1):213-24. PubMed ID: 25492619
[TBL] [Abstract][Full Text] [Related]
12. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis.
Lu Q; Li J; Cao H; Lv C; Wang X; Cao S
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
15. Role of Midkine in Cancer Drug Resistance: Regulators of Its Expression and Its Molecular Targeting.
Saikia M; Cheung N; Singh AK; Kapoor V
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240085
[TBL] [Abstract][Full Text] [Related]
16. Midkine Is a Potential Therapeutic Target of Tumorigenesis, Angiogenesis, and Metastasis in Non-Small Cell Lung Cancer.
Shin DH; Jo JY; Kim SH; Choi M; Han C; Choi BK; Kim SS
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32847073
[TBL] [Abstract][Full Text] [Related]
17. Involvement of midkine in autoimmune and autoinflammatory diseases.
Aynacıoğlu AŞ; Bilir A; Tuna MY
Mod Rheumatol; 2019 Jul; 29(4):567-571. PubMed ID: 30217121
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a poor clinical outcome subtype of primary prostate cancer with Midkine abundance.
Zhou Q; Yang C; Mou Z; Wu S; Dai X; Chen X; Ou Y; Zhang L; Sha J; Jiang H
Cancer Sci; 2022 Nov; 113(11):3698-3709. PubMed ID: 36018546
[TBL] [Abstract][Full Text] [Related]
19. The possible role of Dickkopf-1, Golgi protein- 73 and Midkine as predictors of hepatocarcinogenesis: a review and an Egyptian study.
N Zekri AR; El Kassas M; Salam ESE; Hassan RM; Mohanad M; Gabr RM; M Lotfy M; Abdel-Zaher RAT; Bahnassy AA; Ahmed OS
Sci Rep; 2020 Mar; 10(1):5156. PubMed ID: 32198440
[TBL] [Abstract][Full Text] [Related]
20. Midkine signaling maintains the self-renewal and tumorigenic capacity of glioma initiating cells.
López-Valero I; Dávila D; González-Martínez J; Salvador-Tormo N; Lorente M; Saiz-Ladera C; Torres S; Gabicagogeascoa E; Hernández-Tiedra S; García-Taboada E; Mendiburu-Eliçabe M; Rodríguez-Fornés F; Sánchez-Domínguez R; Segovia JC; Sánchez-Gómez P; Matheu A; Sepúlveda JM; Velasco G
Theranostics; 2020; 10(11):5120-5136. PubMed ID: 32308772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
